Literature DB >> 29582364

Primary Care Providers' Intended Use of Decision Aids for Prostate-Specific Antigen Testing for Prostate Cancer Screening.

Sun Hee Rim1, Ingrid J Hall2, Greta M Massetti2, Cheryll C Thomas2, Jun Li2, Lisa C Richardson2.   

Abstract

Decision aids are tools intended to help people weigh the benefits and harms of a health decision. We examined primary care providers' perspective on use of decision aids and explored whether providers' beliefs and interest in use of a decision aid was associated with offering the prostate-specific antigen (PSA) test for early detection of prostate cancer. Data were obtained from 2016 DocStyles, an annual, web-based survey of U.S. healthcare professionals including primary care physicians (n = 1003) and nurse practitioners (n = 253). We found that the majority of primary care providers reported not using (patient) decision aids for prostate cancer screening, but were interested in learning about and incorporating these tools in their practice. Given the potential of decision aids to guide in informed decision-making, there is an opportunity for evaluating existing decision aids for prostate cancer screening for clinical use.

Entities:  

Keywords:  Decision aids; Prostate cancer; Prostate cancer screening; Prostate specific antigen

Mesh:

Substances:

Year:  2019        PMID: 29582364      PMCID: PMC6158108          DOI: 10.1007/s13187-018-1353-5

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  19 in total

1.  Predictive margins with survey data.

Authors:  B I Graubard; E L Korn
Journal:  Biometrics       Date:  1999-06       Impact factor: 2.571

2.  Assessing the effectiveness of decision aids for decision making in prostate cancer testing: a systematic review.

Authors:  Dragan Ilic; Walid Jammal; Pauline Chiarelli; Robert A Gardiner; Suzanne Hughes; Dana Stefanovic; Suzanne K Chambers
Journal:  Psychooncology       Date:  2015-04-15       Impact factor: 3.894

3.  Early detection of prostate cancer: AUA Guideline.

Authors:  H Ballentine Carter; Peter C Albertsen; Michael J Barry; Ruth Etzioni; Stephen J Freedland; Kirsten Lynn Greene; Lars Holmberg; Philip Kantoff; Badrinath R Konety; Mohammad Hassan Murad; David F Penson; Anthony L Zietman
Journal:  J Urol       Date:  2013-05-06       Impact factor: 7.450

4.  Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2012-07-17       Impact factor: 25.391

5.  No evidence that primary care physicians offer less care to Medicaid, community health center, or uninsured patients.

Authors:  Brian K Bruen; Leighton Ku; Xiaoxiao Lu; Peter Shin
Journal:  Health Aff (Millwood)       Date:  2013-09       Impact factor: 6.301

6.  PSA screening: determinants of primary-care physician practice patterns.

Authors:  G E Tasian; M R Cooperberg; M B Potter; J E Cowan; K L Greene; P R Carroll; J M Chan
Journal:  Prostate Cancer Prostatic Dis       Date:  2011-11-29       Impact factor: 5.554

7.  A decision aid versus shared decision making for prostate cancer screening: results of a randomized, controlled trial.

Authors:  Andrew W Stamm; John S Banerji; Erika M Wolff; April Slee; Sydney Akapame; Kathryn Dahl; John D Massman I I I; Michael C Soung; Kim R Pittenger; John M Corman
Journal:  Can J Urol       Date:  2017-08       Impact factor: 1.344

8.  Decision making in prostate cancer screening using decision aids vs usual care: a randomized clinical trial.

Authors:  Kathryn L Taylor; Randi M Williams; Kimberly Davis; George Luta; Sofiya Penek; Samantha Barry; Scott Kelly; Catherine Tomko; Marc Schwartz; Alexander H Krist; Steven H Woolf; Mary B Fishman; Carmella Cole; Edward Miller
Journal:  JAMA Intern Med       Date:  2013-10-14       Impact factor: 21.873

Review 9.  Substitution of physicians by nurses in primary care: a systematic review and meta-analysis.

Authors:  Nahara Anani Martínez-González; Sima Djalali; Ryan Tandjung; Flore Huber-Geismann; Stefan Markun; Michel Wensing; Thomas Rosemann
Journal:  BMC Health Serv Res       Date:  2014-05-12       Impact factor: 2.655

Review 10.  Wilfully out of sight? A literature review on the effectiveness of cancer-related decision aids and implementation strategies.

Authors:  Anne Herrmann; Elise Mansfield; Alix E Hall; Rob Sanson-Fisher; Nicholas Zdenkowski
Journal:  BMC Med Inform Decis Mak       Date:  2016-03-15       Impact factor: 2.796

View more
  5 in total

1.  Primary Care-Based Staff Ideas for Implementing a Mammography Decision Aid for Women 75+: a Qualitative Study.

Authors:  Mara A Schonberg; Alicia R Jacobson; Gianna M Aliberti; Michelle Hayes; Anne Hackman; Maria Karamourtopolous; Christine Kistler
Journal:  J Gen Intern Med       Date:  2019-09-04       Impact factor: 5.128

2.  Knockdown of anti-silencing function 1B histone chaperone induces cell apoptosis via repressing PI3K/Akt pathway in prostate cancer.

Authors:  Guangye Han; Xinjun Zhang; Pei Liu; Quanfeng Yu; Zeyu Li; Qinnan Yu; Xiaoxia Wei
Journal:  Int J Oncol       Date:  2018-08-16       Impact factor: 5.650

3.  The effects of histone crotonylation and bromodomain protein 4 on prostate cancer cell lines.

Authors:  Xiaolin Xu; Xin Zhu; Feng Liu; Wenlong Lu; Yihan Wang; Jianjun Yu
Journal:  Transl Androl Urol       Date:  2021-02

4.  Evaluating two decision aids for Australian men supporting informed decisions about prostate cancer screening: A randomised controlled trial.

Authors:  Kristen Pickles; Luise Kazda; Alexandra Barratt; Kevin McGeechan; Jolyn Hersch; Kirsten McCaffery
Journal:  PLoS One       Date:  2020-01-15       Impact factor: 3.240

5.  Understanding User Acceptance of Clinical Decision Support Systems to Promote Increased Cancer Screening Rates in a Primary Care Practice.

Authors:  Elizabeth A Kelsey; Jane W Njeru; Rajeev Chaudhry; Karen M Fischer; Darrell R Schroeder; Ivana T Croghan
Journal:  J Prim Care Community Health       Date:  2020 Jan-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.